Since BACH2 plays a tumor-suppressor role in MCL and decreased BACH2 levels lead to BTZ resistance [13], we first determined the BACH2 levels in one BTZ-sensitive cell line Jeko and one BTZ-resistant MCL cell line REC-1 [12]. The gene discussed is BACH2; the disease is neoplasm.